Covid-19: Corrida por vacina se acirra com testes em humanos na Alemanha
The article delves into efforts being made by pharmaceutical companies around the world, including in Germany, China, the UK, the United States, and Norway in creating and testing vaccine candidates for COVID-19. The article reports that while some companies have already begun testing vaccine candidates, others are still conducting preliminary research.Â
The article also looks at the potential barriers expected in the creation and distribution of a vaccine, noting that thorough testing is crucial in developing an option that is safe, effective, and accessible. The article quotes Danny Edwards, Research Programme Manager for the Access to Medicine Index, regarding issues of accessibility surrounding an eventual vaccine:Â
"Nobody should be left behind. This has a moral aspect, but it also has a practical aspect: for a pandemic vaccine to be effective, it needs to be available globally."